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1. Introduction
Natural polymers and their application in the pharmaceutical industry are covered by the 
presence of synthetic polymers. Natural polysaccharides have gained popularity in the phar-
maceutical, biomedical and food industry owing to their lucrative properties, namely biode-
gradability and biocompatibility and nontoxicity [1].
Polysaccharides can be obtained from a number of sources including seaweeds, bacteria, 
fungi and plants. When the polysaccharide is composed of only one kind of repeating mono-
saccharide, it is known as homo-polysaccharides, e.g., starch and cellulose. However, if the 
polysaccharide is composed of two or more different monomeric units, it is termed as hetero-
polysaccharides, e.g., agar, alginate and carrageenan [2].
Further, the polysaccharides can be anionic, cationic and nonionic. Because they are extracted 
from natural resources, their composition and physicochemical properties vary considerably. 
Seaweed may belong to one of the several groups of multicellular algae: the red algae, green 
algae and brown algae. They are the rich sources of polysaccharides. Among the seaweed poly-
saccharides, alginates and carrageenan have been widely characterised and studied for the pos-
sible drug delivery application as well as their therapeutic potentials. In subsequent section of 
this introductory chapter, the therapeutic potential of these two polysaccharides is described.
2. Therapeutic potential of alginate
Alginate is derived from marine brown algae cell walls. Alginate is an anionic polysac-
charide consisting of linear copolymer chain of (1-4)-linked β-D-mannuronic acid and α-L-
guluronic acid in different arrangements of residues. Alginate is a natural, biodegradable and 
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mucoadhesive polymer that does not produce toxicity in administration [3, 4]. This seaweed 
polysaccharide is most widely studied for the development of various kinds of drug deliv-
ery carriers. Its gel-forming ability in presence of divalent calcium ions has been extensively 
utilised for the fabrication of microparticles, nanoparticles and hydrogels in an attempt to 
achieve control drug release profiles. However, its bioactive potential has also been investi-
gated and is described as follows.
Ueno and Oda [5] studied the effect of molecular weight and ratio of mannuronic acid/guluronic 
acid residues on TNF-α (tissue necrosis factor alpha) reducing activity in murine macrophage 
cell line. The alginates with molecular weight of 38,000 and the said ratio of 2.24 demonstrated 
potent TNF-α-inducing activity. They further noted that lyase depolymerised alginates were 
keen on inducing nitric oxide production from RAW264.7 cells compared to native alginate. 
However, both the polymers were equally effective with regards to their hydroxyl radical scav-
enging activities.
Its biocompatibility and similar gel texture and stiffness to that of the extracellular matrix 
have promoted alginate for its application in the field of tissue engineering and regeneration. 
Injectable alginate implants have been found to possess great potential in inhibiting the dam-
aging events after myocardial infarction, leading to myocardial repair and tissue reconstruc-
tion [6]. Park et al. [7] depolymerised alginate following extraction from Laminaria japonica, 
and they found that the alginate lyase enzyme-treated 307 kDa alginate reduced the accumu-
lation of lipid droplet and triglyceride in 3 T3-L1 preadipocytes in a dose-dependent man-
ner and can be developed further for antiobesity treatment. The TNF-α secretion-inducing 
activity of alginate oligomers following enzymatic (lyase) hydrolysis of polyguluronate and 
polymannuronate differed in RAW264.7 cells and was dependent on the oligomer structures 
[8]. The encouraging preclinical results of cell-free alginate hydrogel implants in dogs with 
heart failure towards ventricle restoration have led to the initiation of clinical investigation 
for intramyocardial delivery of alginate implants in patients with acute myocardial infarction 
[9]. Houghton et al. [10] demonstrated that alginate in a bread vehicle can maintain its lipase 
inhibition properties despite cooking and digestion and therefore offers potential for the treat-
ment of obesity. Wilcox et al. [11] reported that high-guluronic acid alginates isolated from 
Laminaria hyperborea seaweed could inhibit pancreatic lipase to a significantly higher degree 
than that obtained from Lessonia nigrescens. Therefore, lipase inhibition could be attributed to 
the variable structure of alginate. Their food use at high concentration could reduce the uptake 
of dietary triacylglycerol aiding in weight management. In another work by Chater et al. [12], 
the inhibitory effect of alginate on the gastro-oesophagus reflux aggressors trypsin and pepsin 
was investigated. The pepsin activity was reduced by up to 53.9% in vitro, although trypsin 
inhibition was trivial. The pepsin-reducing activity was correlated with the frequency of man-
nuronate residues in alginate. A significant proteolytic inhibition of dietary protein substrates 
was noted in the gastric phase of digestion, but not in the small intestinal phase.
3. Therapeutic potential of carrageenan
Carrageenan is a naturally occurring anionic sulphated linear polysaccharide extracted from 
certain red seaweed of the Rhodophyceae family [13]. Carrageenan consists of alternate units 
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of D-galactose and 3,6-anhydro-galactose joined by α-1,3- and β-1,4-glycosidic linkage. Based 
on the amount and position of sulphate groups, carrageenan can be classified into lambda 
(λ), kappa (κ), iota (ι), nu (υ), mu (μ), theta (θ) and Ksi (ξ), all containing about 22–35% of sul-
phate groups [14]. Carrageenans have been extensively investigated for their anticoagulant, 
antiviral, cholesterol-lowering effects and immunomodulatory and antioxidant activity both 
in vitro and in vivo [15].
Sokolova et al. [16] reported that the antioxidant activity of carrageenans, i.e., their inhibi-
tory effects on hydroxyl radicals and superoxide anion radicals, depends on the polysaccha-
ride structure. Yuan et al. [17, 18] hydrolysed kappa-carrageenan to obtain oligosaccharides 
which were further sulphated, acetylated and phosphorylated. All the derivatives exhibited 
significant antioxidant activities; however, their antioxidant activity differs in different sys-
tems. The sulphated and acetylated derivatives scavenged superoxide radicals; the acetylated 
derivatives scavenged hydroxyl radicals, whereas the phosphorylated ones scavenged both 
hydroxyl radicals and DPPH radicals. The chemical modification of carrageenan oligosac-
charides could enhance their antioxidant activity in vitro.
Carrageenan demonstrated encouraging antiviral activity against several animal viruses [19]. 
At a dose of 5 μg/ml, the destruction of the cell monolayer by herpes simplex virus type 1 
(HSV-1) could be prevented. No evidence of cytotoxic effects was apparent up to a carra-
geenan concentration of 200 μg/ml. Girond et al. [20] reported a potent inhibitory effect of sul-
phated iota-, lambda- and kappa-carrageenans on the replication of hepatitis A virus (HAV) 
in the human hepatoma cell line, without any cytotoxic effects up to a strength of 200 μg/ml. 
Based on their selectivity indices, lota- and lambda-carrageenan was identified as promising 
candidates for chemotherapy of acute hepatitis A.
Carrageenans from Gigartina acicularis and Eucheuma denticulatum are more sulphated than 
those from Kappaphycus cottonii. At 0.75 mg/ml, no virucidal activity against HHV-1 or poliovi-
rus was noticed. Their antiviral effect could be due to lower inhibition of the virus attachment 
and by the interference in the virus replication cycle [21].
Algal polysaccharides such as carrageenan are good sources of dietary fibre. Previous studies 
have shown that native carrageenan (κ) extracted from Kappaphycus alvarezii and commercial 
carrageenan have hypoglycaemic effects [22]. Panlasigui et al. [23] demonstrated that regular 
inclusion of carrageenan in the diet may result in reduced blood cholesterol and lipid lev-
els in human subjects. Anderson et al. [24] reported that λ-carrageenans and κ-carrageenans 
from Chondrus crispus and Polyides rotundus possessed anticoagulant activity on intravenous 
injection in the rabbit. The differences in sulphate content between the carrageenans did not 
directly correlate with variable anticoagulant action and toxicity.
4. Conclusion
The literature reports suggested that seaweed polysaccharides possess potential pharma-
cological activities including antidiabetic, antiviral, antioxidant, anticoagulant, pepsin- and 
lipase-reducing and lipid-lowering activity. These polysaccharides either in their native form 
or modified form can be developed as therapeutic agents for the treatment of various diseases. 
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Further, they have been widely investigated as polymers for designing drug delivery carriers 
and tissue scaffolds. Overall, the exploration of these seaweed polysaccharides must be more 
focused to make them clinically useful as therapeutic agents.
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